Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | AZN | AMGN | GILD | VRTX |
| Company | Structure Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 21.60 | 74.15 | 294.73 | 110.51 | 455.39 |
| High | 22.45 | 74.98 | 299.49 | 111.37 | 460.10 |
| Low | 21.26 | 73.91 | 294.07 | 109.48 | 454.00 |
| Last | 21.68 | 74.42 | 295.22 | 109.98 | 455.45 |
| Change | -0.54 | -0.58 | -2.07 | -2.07 | -4.61 |
| % Change | -2.43% | -0.77% | -0.70% | -1.85% | -1.00% |
| Volume | 669,700 | 3,131,500 | 2,191,200 | 8,150,100 | 1,021,500 |
| 20-Day Average Volume | 835,135 | 4,124,075 | 2,558,090 | 7,865,970 | 1,338,480 |
| Previous Close | 22.22 | 75.00 | 297.29 | 112.05 | 460.06 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.79 | 71.77 | 283.90 | 109.15 | 445.49 |
| 20-Day Raw Stochastic | 23.58% | 86.85% | 86.56% | 73.36% | 85.17% |
| 20-Day Relative Strength | 45.81% | 59.74% | 57.49% | 53.72% | 49.92% |
| Weighted Alpha | -58.03 | -3.14 | -1.38 | +60.67 | -5.58 |
| Today's Opinion | 88% Sell | 8% Buy | 8% Sell | 88% Buy | 56% Sell |
| Previous Opinion | 88% Sell | 24% Buy | 8% Buy | 88% Buy | 56% Sell |
| Last Month's Opinion | 40% Sell | 72% Sell | 72% Sell | 8% Buy | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.60% since 06/06/25 | +2.11% since 06/06/25 | +1.68% since 06/06/25 | -2.21% since 06/06/25 | +1.10% since 06/06/25 |
| Low | 20.27 on 06/09/25 | 72.54 on 06/09/25 | 287.54 on 06/09/25 | 108.90 on 06/12/25 | 441.92 on 06/10/25 |
| High | 24.05 on 06/11/25 | 75.38 on 06/12/25 | 299.49 on 06/13/25 | 113.52 on 06/09/25 | 460.33 on 06/11/25 |
| 1-Month | |||||
| %Chg | -9.25% since 05/13/25 | +9.89% since 05/13/25 | +9.16% since 05/13/25 | +8.43% since 05/13/25 | +5.43% since 05/13/25 |
| Low | 20.27 on 06/09/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 97.86 on 05/15/25 | 416.60 on 05/14/25 |
| High | 26.25 on 05/16/25 | 75.38 on 06/12/25 | 299.49 on 06/13/25 | 113.52 on 06/09/25 | 460.33 on 06/11/25 |
| 3-Month | |||||
| %Chg | +6.27% since 03/13/25 | -2.73% since 03/13/25 | -5.57% since 03/13/25 | -2.97% since 03/13/25 | -9.44% since 03/13/25 |
| Low | 13.22 on 04/09/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 28.68 on 05/02/25 | 77.76 on 03/17/25 | 319.31 on 03/18/25 | 114.75 on 04/03/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -30.62% since 12/13/24 | +11.78% since 12/13/24 | +9.09% since 12/13/24 | +19.73% since 12/13/24 | -1.79% since 12/13/24 |
| Low | 13.22 on 04/09/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 88.57 on 01/10/25 | 377.85 on 12/19/24 |
| High | 32.00 on 12/16/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,243,196 | 230,797,040 | 158,741,568 | 136,807,312 | 116,958,200 |
| Shares Outstanding, K | 57,343 | 3,101,277 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -122,530,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -46,830,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | -1.87 | 0.38 | 0.51 | 0.29 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.27 on 05/08/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 05/08/25 | 07/24/25 | 08/05/25 | 04/24/25 | 08/07/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 06/13/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.36 | 14.32 | 14.48 | 0.00 |